Treatment Outcomes of Primary vs. Referred Patients with Multiple Myeloma Receiving Talquetamab or Teclistamab

被引：0
|
作者：
Fries, Gina [1 ]
Alshlah, Ali [1 ]
Baran, Andrea [1 ]
Lipe, Brea [2 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY USA
[2] UR Med, Dept Med, Rochester, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-119
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [21] Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
    Hermann Einsele
    Philippe Moreau
    Nizar Bahlis
    Manisha Bhutani
    Laure Vincent
    Lionel Karlin
    Aurore Perrot
    Hartmut Goldschmidt
    Niels W. C. J. van de Donk
    Enrique M. Ocio
    Joaquin Martinez-Lopez
    Paula Rodríguez-Otero
    Dominik Dytfeld
    Joris Diels
    Vadim Strulev
    Imene Haddad
    Thomas Renaud
    Eric Ammann
    Jedelyn Cabrieto
    Nolen Perualila
    Ryan Gan
    Youyi Zhang
    Trilok Parekh
    Claire Albrecht
    Katja Weisel
    Maria-Victoria Mateos
    Advances in Therapy, 2024, 41 : 1576 - 1593
  • [22] Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
    Einsele, Hermann
    Moreau, Philippe
    Bahlis, Nizar
    Bhutani, Manisha
    Vincent, Laure
    Karlin, Lionel
    Perrot, Aurore
    Goldschmidt, Hartmut
    van de Donk, Niels W. C. J.
    Ocio, Enrique M.
    Martinez-Lopez, Joaquin
    Rodriguez-Otero, Paula
    Dytfeld, Dominik
    Diels, Joris
    Strulev, Vadim
    Haddad, Imene
    Renaud, Thomas
    Ammann, Eric
    Cabrieto, Jedelyn
    Perualila, Nolen
    Gan, Ryan
    Zhang, Youyi
    Parekh, Trilok
    Albrecht, Claire
    Weisel, Katja
    Mateos, Maria-Victoria
    ADVANCES IN THERAPY, 2024, 41 (04) : 1576 - 1593
  • [23] Model-Based Exploration of the Impact of Prophylactic Tocilizumab on IL-6 Dynamics in Multiple Myeloma Patients Receiving Teclistamab Treatment
    Zhou, Jia
    Vishwamitra, Deeksha
    Guo, Yue
    Verona, Raluca
    Puchalt, Alfredo Perales
    Stephenson, Tara
    Hodin, Caroline
    Banerjee, Arnob
    Chastain, Katherine
    Haddish-Berhane, Nahor
    Wang, Weirong
    BLOOD, 2023, 142
  • [24] Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    Hungria, Vania
    Iida, Shinsuke
    Bahlis, Nizar J.
    Nahi, Hareth
    Magen, Hila
    Cavo, Michele
    Hulin, Cyrille
    White, Darrell
    De Stefano, Valerio
    Fastenau, John
    Slavcev, Mary
    Heuck, Christoph
    Qin, Xiang
    Pei, Huiling
    Masterson, Tara
    Lantz, Kristen
    Gries, Katharine S.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 619 - 631
  • [25] Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
    Saad Z. Usmani
    Maria-Victoria Mateos
    Vania Hungria
    Shinsuke Iida
    Nizar J. Bahlis
    Hareth Nahi
    Hila Magen
    Michele Cavo
    Cyrille Hulin
    Darrell White
    Valerio De Stefano
    John Fastenau
    Mary Slavcev
    Christoph Heuck
    Xiang Qin
    Huiling Pei
    Tara Masterson
    Kristen Lantz
    Katharine S. Gries
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 619 - 631
  • [26] Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
    Ariana Berenson
    Suzie Vardanyan
    Michael David
    James Wang
    Nika Manik Harutyunyan
    Jillian Gottlieb
    Ran Halleluyan
    Tanya M. Spektor
    Kyle A. Udd
    Shahrooz Eshaghian
    Youram Nassir
    Benjamin Eades
    Regina Swift
    James R. Berenson
    Annals of Hematology, 2017, 96 : 449 - 459
  • [27] Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
    Berenson, Ariana
    Vardanyan, Suzie
    David, Michael
    Wang, James
    Harutyunyan, Nika Manik
    Gottlieb, Jillian
    Halleluyan, Ran
    Spektor, Tanya M.
    Udd, Kyle A.
    Eshaghian, Shahrooz
    Nassir, Youram
    Eades, Benjamin
    Swift, Regina
    Berenson, James R.
    ANNALS OF HEMATOLOGY, 2017, 96 (03) : 449 - 459
  • [28] Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis
    Khouderchah, Christy J.
    Ochs, Madeleine
    Pianko, Matthew
    Mahmoudjafari, Zahra
    Snyder, Jordan
    Ahmed, Iman
    Campagnaro, Erica
    Nachar, Victoria R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (06) : 1089 - 1095
  • [29] Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma
    Tabbara, Nadeem
    Singel, Michael
    Allen, Natalie
    Mooney, Kathy
    Shedeck, Audra
    Zukas, Amber
    Campion, Kate
    Sollenberger, Callan
    Gocke, Christian Burris
    Ali, Syed Abbas
    Huff, Carol Ann
    Imus, Philip H.
    Waheed, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma
    Rudzianskiene, Milda
    Inciura, Arturas
    Gerbutavicius, Rolandas
    Rudzianskas, Viktoras
    Macas, Andrius
    Simoliuniene, Renata
    Dambrauskiene, Ruta
    Kiavialaitis, Greta Emilia
    Juozaityte, Elona
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 742 - 749
12345